Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04MAM
|
|||
Former ID |
DNC004641
|
|||
Drug Name |
Sulfamic acid chroman-2-ylmethyl ester
|
|||
Synonyms |
CHEMBL180475; 835894-63-8; Sulfamic acid, (3,4-dihydro-2H-1-benzopyran-2-yl)methyl ester; Sulfamic acid chroman-2-ylmethyl ester; SCHEMBL5274616; CTK3D1605; DTXSID80463432; BDBM50163317; (3,4-dihydro-2H-chromen-2-yl)methyl sulfamate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H13NO4S
|
|||
Canonical SMILES |
C1CC2=CC=CC=C2OC1COS(=O)(=O)N
|
|||
InChI |
1S/C10H13NO4S/c11-16(12,13)14-7-9-6-5-8-3-1-2-4-10(8)15-9/h1-4,9H,5-7H2,(H2,11,12,13)
|
|||
InChIKey |
OXNGFJDSVRPPCH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 835894-63-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase II (CA-II) | Target Info | Inhibitor | [1] |
KEGG Pathway | Nitrogen metabolism | |||
Proximal tubule bicarbonate reclamation | ||||
Collecting duct acid secretion | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. J Med Chem. 2005 Mar 24;48(6):1941-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.